SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
about
Multiple serotonin receptors: opportunities for new treatments for obesity?The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo.The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro.
P2860
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@en
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@nl
type
label
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@en
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@nl
prefLabel
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@en
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@nl
P2093
P1476
SDZ 216-525, a selective and potent 5-HT1A receptor antagonist.
@en
P2093
P304
P356
10.1016/0922-4106(93)90150-8
P407
P50
P577
1993-02-01T00:00:00Z